The increased concentration of IL-2 may result from its regulatory role in inhibiting excessive activation of the immune system; however, considering the studies of patients with severe COVID-19, its role in the initial phase of SARS-CoV-2 infection requires further research.
No takes yet. Share an insight, caveat, or question.
Łodyga et al. (2023) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: